AI Science Tracker
EN

A Full-Spectrum Generative Lead Discovery (FSGLD) pipeline via DRUG-GAN: A multiscale method for drug-like/target-specific compound library generation.

Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310018 Zhejiang, China.; School of Medicine, Shanghai University, 200444 Shanghai, China. · 12 May 2025 · computer science

Discovery

A Full-Spectrum Generative Lead Discovery (FSGLD) pipeline via DRUG-GAN: A multiscale method for drug-like/target-specific compound library generation.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The generative pipeline produced candidates for experimental screening; the primary preprint reports one tested candidate with measured CB2 binding, while the journal version also reports HER4 work. This supports a narrow initial-hit result, not a validated therapeutic.

Technology: Journal Methods/Results and the Research Square v1 PDF establish the generative operation, screening workflow, nine-compound assay and limited CB2 binding result; preprint posted 2025-05-12.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Journal Methods/Results and the Research Square v1 PDF establish the generative operation, screening workflow, nine-compound assay and limited CB2 binding result; preprint posted 2025-05-12.
Limitation / still unknown
The evidence supports initial measured CB2 binding (and journal-version HER4 work), not a validated therapeutic, animal efficacy or human benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC13715712

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse computer science discoveries.